Enhanced Group announced that it has secured a $50 million private investment in public equity (PIPE) financing led by Apeiron Investment Group, the family office of Enhanced Co-Founder and Chairman Christian Angermayer, with participation from Co-Founder and CEO Maximilian Martin and a group of global institutional investors.
The financing is expected to provide the company with sufficient capital to fund operations through its targeted achievement of operational profitability in 2027.
Under the agreement, Enhanced will issue approximately 12.85 million shares of Class A common stock at $3.89 per share, matching the closing price of the stock on June 12, 2026, along with an equal number of warrants carrying an exercise price of $3.89 per share. The first tranche of the financing is expected to close around June 17, 2026, with the remaining two tranches anticipated to close within 45 days, subject to customary conditions.
The company plans to use the proceeds for working capital and general corporate purposes, including accelerating the expansion of its telehealth and consumer health platform.
The financing follows the inaugural Enhanced Games, which the company said attracted more than one billion viewers globally and featured one world record and 21 personal best performances across 42 athletes. Enhanced noted that the event generated $32 million in sponsorship contract value, and management believes the Enhanced Games could become profitable on a standalone basis as early as 2027.
Enhanced plans to expand beyond its annual competition by hosting additional sporting events throughout the year, with further details expected to be announced in the future.
The company said the sports platform serves as a customer acquisition engine for its Live Enhanced consumer platform, which offers products and protocols focused on health optimization, longevity, performance, and recovery. Management believes the strategy could significantly reduce customer acquisition costs compared with peers by leveraging awareness generated through the sporting events.
Enhanced’s long-term strategy centers on converting growing interest in performance enhancement, peptides, longevity, and preventative healthcare into recurring demand across its telehealth, supplements, and therapeutics businesses.
Cantor is serving as exclusive placement agent for the financing. DLA Piper is acting as legal advisor to Cantor, while Cooley is serving as legal advisor to Enhanced.
Enhanced is a publicly traded sports competition and performance products company focused on health optimization and performance medicine. Through its Live Enhanced platform, the company provides consumers with products and protocols aimed at improving health, vitality, and longevity.
KEY QUOTES:
“The inaugural Enhanced Games exceeded our expectations, engaging more than one billion viewers globally. We believe this unprecedented awareness creates a powerful customer acquisition engine for our Live Enhanced consumer platform. With this financing, we are positioned to accelerate growth, scale our platform aggressively, and execute on our path to profitability.”
Maximilian Martin, Co-Founder and Chief Executive Officer of Enhanced
“The success of the Enhanced Games and the traction we are already seeing in our consumer business have, in my view, significantly de-risked the investment case. The question is no longer whether demand exists, but how quickly we can execute and how much of this massive global market we can capture. I am more confident than ever in the company’s future trajectory and delighted to double down on my investment.”
Christian Angermayer, Co-Founder and Chairman of Enhanced
